The American Liver Foundation has put together a fantastic new video that examines the progression of nonalcoholic fatty liver disease (NALF) to nonalcoholic steatohepatitis (NASH). It is full of information on causes, progression, and treatment options.
Click here to check out the video.
The American Liver Foundation has just released a new and very detailed infographic on NAFLD/NASH. This highlights the biggest concerns with NASH and presents the staggering numbers in a very easy-to-understand one-page format.
Continue reading “Check out this amazing NAFLD/NASH Infographic”
CNBC has a special article on the NAFLD/NASH epidemic in America, with a bunch of sobering statistics. Continue reading “More than 80 million Americans have this deadly disease, and many don’t even know it”
Gilead was the first bio-pharmaceutical company to begin major research into NASH related treatments. They have since been joined by dozens of others attempting to gain a foothold in the space, which is expected to be lucrative based on the percentage of population at risk.
They recently sent Dr. Mani Subramanian, PhD, to speak at the 2018 International Liver Congress, Continue reading “Gilead presents new NASH treatment data”
NASH AWARE 